Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.
所公开的是具有 NPR-B 激动活性的新型化合物。优选化合物是线性肽,含有 8-13 个通过肽键相互连接的常规或非常规 L 或 D 氨基酸残基。
ALIPHATIC POLYCARBONATE COMPOSITIONS AND METHODS
申请人:Novomer, Inc.
公开号:EP2992031A2
公开(公告)日:2016-03-09
NPR-B Agonists
申请人:Shire Orphan Therapies GmbH
公开号:US20170313743A1
公开(公告)日:2017-11-02
Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds.